MP

Mayur Pramod Panjabi

Active Director Director DIN 10783155
DIN 10783155 First appointment Sep 2024 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mayur Pramod Panjabi

Data last updated:

Mayur Pramod Panjabi is a Director at John Mark Pharmaceuticals Limited (since 2024). The company operates in Trading.

DIN 10783155
Primary Designation Director
Industry Trading
First Appointment 18 Sep 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
John Mark Pharmaceuticals Limited U51909PN2022PLC216794
Director18 Sep 20242022Active

Directorship timeline

Open interactive timeline →
John Mark Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Mayur Pramod Panjabi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayur Pramod Panjabi

Mayur Pramod Panjabi currently holds 1 directorship: John Mark Pharmaceuticals Limited (Director, since 18 Sep 2024).

Mayur Pramod Panjabi was first appointed on 18 Sep 2024 as Director at John Mark Pharmaceuticals Limited.

The current boards of Mayur Pramod Panjabi's companies include Arjunsingh Jyotsingh Chavan (John Mark Pharmaceuticals Limited), Dinesh Pralhadsing Rajput (John Mark Pharmaceuticals Limited), Ravindra Utreshwar Ghumbre (John Mark Pharmaceuticals Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available